• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

GoodRx Offers Up to 43% Discounts on Fertility Treatments, Launches Fertility Hub for Patient Supports

by Jasmine Pennic 05/22/2024 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
GoodRx Offers Up to 43% Discounts on Fertility Treatments, Launches Fertility Hub for Patient Supports

What You Should Know: 

– GoodRx, a leading platform for prescription medication savings, announced today it’s offering significant discounts of up to 43% on fertility treatments based on the best available GoodRx price. This move aims to help families and individuals manage the often-prohibitive costs associated with in vitro fertilization (IVF) and other fertility treatments.

– By offering substantial discounts and educational resources, GoodRx is committed to making fertility care more accessible. 

Easing the Financial Burden of Fertility Care

The high cost of fertility treatments is a major barrier for many seeking to expand their families. A single IVF cycle can range from $15,000 to $30,000, with medication costs representing a significant portion of this expense. Many medications used during IVF cycles require individual dosing, further adding to the financial burden. Additionally, with success rates often requiring multiple cycles, the total cost can quickly become overwhelming.

While insurance coverage for fertility treatments is increasing, it rarely covers the entire cost. GoodRx’s discounts aim to bridge this gap, offering savings of up to 43% on generic and brand-name medications used throughout the IVF process.

GoodRx Fertility Hub: Empowering Patients on Their Journey

Understanding the complexities of fertility medications and the IVF process can be daunting. To support individuals navigating fertility treatments, GoodRx has launched the GoodRx Fertility Hub. This comprehensive online resource provides:

  • Credible Information: Easy-to-understand articles address common fertility concerns, treatment options, and the IVF process itself.
  • Actionable Insights: The Hub provides practical guidance to help patients navigate their fertility journey.
  • Trusted Expertise: Content is researched and written by a team of editorial and medical experts, including doctors and pharmacists.
“Hundreds of thousands of people every year are faced with an incredibly challenging decision: do I reevaluate my plans to expand my family, or pay thousands of dollars to pursue fertility treatments? GoodRx is here to relieve some of that financial burden and take some of the stress out of the reproductive journey,” said Dorothy Gemmell, Chief Commercial Officer, GoodRx. “Through savings on both generic and brand-name medications, GoodRx helps users afford their fertility treatments so fewer people have to choose between their future and their finances.”

Individuals seeking to learn more or explore GoodRx’s fertility savings opportunities can download the GoodRx app or visit their website at https://www.goodrx.com/go/fertility.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Femtech

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |